ABSTRACT
CASE: Minimal information is available regarding coronavirus disease-19 (COVID-19) patients with hemophilia A. Coagulopathy is a major pathophysiological characteristic of COVID-19; however, because of a paucity of data, it is not clear whether these patients with hemophilia are more or less prone to the severe form of the COVID-19 disease. We report the case of a hemophilic patient with confirmed COVID-19 after total knee arthroplasty. CONCLUSION: This case highlights the idea that patients with a congenital hypocoagulability stated as haemophilia may be protected against COVID-19 hypercoagulability-related adverse effects. Thromboprophylaxis with low-molecular-weight heparin should be evaluated in patients with hemophilia and COVID-19 disease.